1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 94 Hits
  • Search Condition : Filter (MeSH = Liver Neoplasms / pathology)
Species Resource
Human and Animal Cells IMR-32 Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
Prokaryotes E. coli ME8079(AB1157) , ME8087(AB2463) , ME8080(AB1885) Effects of phenyl derivatives of dihydropyrazines with ability to generate radical species on Escherichia coli.
DNA material pEF-BOSneoSE-mNotch2 RAMIC (RDB06772) NOTCH2 signaling confers immature morphology and aggressiveness in human hepatocellular carcinoma cells.
Human and Animal Cells Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
Human and Animal Cells Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Human and Animal Cells Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
Human and Animal Cells High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.
Human and Animal Cells Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Human and Animal Cells Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Human and Animal Cells High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.
Human and Animal Cells Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.
Human and Animal Cells MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.
Human and Animal Cells Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Human and Animal Cells Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
Human and Animal Cells Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes.
Human and Animal Cells Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
Human and Animal Cells The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
Human and Animal Cells Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo.
Human and Animal Cells BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.
Human and Animal Cells Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.